Perrin Brueckner

Perrin Brueckner is an experienced professional in quality assurance and quality control, currently serving as the Director of QA/QC Technical Operations at NOVAVAX INC since May 2022. Prior experience includes roles at Eli Lilly and Company from July 2019 to May 2022 as a TS/MS Senior Principal Scientist, and at Immunomedics as QC Manager from February 2018 to July 2019. Perrin Brueckner previously held various quality control positions at Eli Lilly and Company from June 2011 to February 2018, including QC Principal Research Associate, QC Senior Research Associate, and QC Research Associate. Earlier experience includes roles at ImClone Systems, where responsibilities spanned from QC Analyst to QA Documentation Coordinator from April 2007 to May 2011. Educational background includes a degree in Biochemistry from Arizona State University, attended from 2003 to 2006, and previous education at Kamehameha Schools from 1999 to 2002.